Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation, bispecific and multifunctional biotherapeutics, initially
Independently analyzes, interprets and reports clinical PK data as a member of several multidisciplinary development program teams. Works with preclinical teams to design PK/TK studies in advance of IND filings. Works with clinical tea[...]